Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.44 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.40 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.38 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.37 |
| ▸ | CCR5 | P51681 | 3/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9328830 | 1.00 | EPHX2 (0.44) | EPHX2SLC18A3HSD17B2AGTR2CCR5 | |
| SCHEMBL9328813 | 1.00 | EPHX2 (0.44) | EPHX2SLC18A3HSD17B2AGTR2CCR5 | |
| SCHEMBL9328821 | 1.00 | EPHX2 (0.44) | EPHX2SLC18A3HSD17B2AGTR2CCR5 | |
| SCHEMBL9328937 | 1.00 | EPHX2 (0.44) | EPHX2SLC18A3HSD17B2AGTR2CCR5 | |
| SCHEMBL9542527 | 0.87 | EPHX2 (0.39) | EPHX2SLC18A3CCR5 | |
| SCHEMBL9328925 | 0.76 | TSHR (0.45) | EPHX2 | |
| SCHEMBL9453530 | 0.76 | TSHR (0.45) | EPHX2 | |
| SCHEMBL9328917 | 0.76 | TSHR (0.45) | EPHX2 | |
| SCHEMBL9328931 | 0.76 | TSHR (0.45) | EPHX2 | |
| SCHEMBL9331244 | 0.73 | EPHX2 (0.46) | EPHX2SLC18A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5292884-A | Cyclic hydroxamic acids | BIOMIDE INVESTMENT LIMITED PARTNERSHIP (US) | 1994-03-08 | — | — | US | disclosed |